CN104173511A - Medicine for treating osteoarthritis - Google Patents

Medicine for treating osteoarthritis Download PDF

Info

Publication number
CN104173511A
CN104173511A CN201410440521.9A CN201410440521A CN104173511A CN 104173511 A CN104173511 A CN 104173511A CN 201410440521 A CN201410440521 A CN 201410440521A CN 104173511 A CN104173511 A CN 104173511A
Authority
CN
China
Prior art keywords
medicine
osteoarthritis
powder
taking
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201410440521.9A
Other languages
Chinese (zh)
Inventor
赵翠燕
宫相泽
周美玲
赵庆沛
鲁妮
于延学
黄桂芝
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201410440521.9A priority Critical patent/CN104173511A/en
Publication of CN104173511A publication Critical patent/CN104173511A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The invention discloses a medicine for treating osteoarthritis. The medicine is characterized by comprising the following components by weight percent: 10-15% of manis pentadactyla, 6-12% of scorpio, 6-12% of centipede, 10-15% of red flower, 6-12% of prepared myrrh, 10-15% of radix cyathulae, 10-15% of peach kernel, 10-15% of toosendan fruit and 10-15% of radix glycyrrhizae. The preparation and taking methods comprise the following steps: weighing the traditional Chinese herbal medicines according to the weight ratio; drying and grinding the traditional Chinese herbal medicines into powder, or crushing and screening by a sieve of 200 meshes; taking the medicine after mixing the powder with 50-100ml of warm boiled wine; as to a poor drinker, adding a proper amount of brown sugar to take the medicine after mixing the powder with the warm boiled water for 7.5g twice a day; and taking the medicine at night every two days, and then properly sweating, 20 days as a treatment course. According to the medicine, the problems that the existing oral western medicine is large in side effect, high in recurrence rate after drug discontinuance, and the like are solved, and the medicine is suitable for treatment of the osteoarthritis.

Description

A kind of medicine for the treatment of osteoarthritis
Technical field
The present invention relates to medical making field, is a kind of Chinese medicine for the treatment of osteoarthritis specifically.
Background technology
Osteoarthritis is a kind of person in middle and old age's commonly encountered diseases, its basic pathological changes is: the degeneration of carrying out property articular cartilage, destruction and forfeiture, articular cartilage and subchondral bone edge hyperosteogeny that multiple paathogenic factor causes form, and cause thus a series of joint sings and symptoms.Clinical manifestation is arthralgia, stiff, swelling, deformity and dysfunction, and often with Secondary cases synovitis, sickness rate increased and increases gradually with the age.Primary disease belongs to traditional Chinese medical science arthromyodynia category, how because of deficiency of the liver and kindey, and wind-cold damp pathogen numbness resistance meridians joint, qi depression to blood stasis and falling ill.
The oral drugs for the treatment of osteoarthritis on modern clinic mostly are Western medicine preparation, as indometacin, diclofenac ibuprofen, meloxicam etc., these medicine side effect are large, can cause that feeling sick appears in digestive tract reaction, vomiting, even ulcer, hemorrhage, perforation etc. occur, after drug withdrawal, relapse rate is high, and can not effect a radical cure.
Summary of the invention
The present invention, for solving the problems such as existing Drug therapy osteoarthritis cure rate is low, side effect is large, invents a kind of Chinese medicine for the treatment of osteoarthritis.
Technical scheme of the present invention is, a kind of medicine for the treatment of osteoarthritis, and its special character is:
Component is: Squama Manis, Scorpio, Scolopendra, Flos Carthami, Myrrha (processed), Radix Cyathulae, Semen Persicae, Fructus Toosendan, Radix Glycyrrhizae;
Components by weight is: Squama Manis 10-15%, Scorpio 6-12%, Scolopendra 6-12%, Flos Carthami 10-15%, Myrrha (processed) 6-12%, Radix Cyathulae 10-15%, Semen Persicae 10-15%, Fructus Toosendan 10-15%, Radix Glycyrrhizae 10-15%;
Make and instructions of taking: take by weight Squama Manis, Scorpio, Scolopendra, Flos Carthami, Myrrha (processed), Radix Cyathulae, Semen Persicae, Fructus Toosendan, 9 kinds of Chinese crude drugs of Radix Glycyrrhizae, dry dry after, be ground into smalls, or rear 200 mesh sieves of crossing of pulverizing, each 7.5g, every day 2 times, opens wine 50-100ml with temperature and takes after mixing it with water, the next day evening clothes after appropriate diaphoresis, within 20 days, be a course for the treatment of.To alcoholic intolerance person, add appropriate brown sugar with warm water and take after mixing it with water.
Fang Zhong: Squama Manis, promoting blood circulation to restore menstrual flow, is good at walking to alter, and property specially row is loose, can dredging collateral and reach disease institute; Scorpio, Scolopendra, mutual reinforcement between is use, removing obstruction in the collateral to relieve pain; Flos Carthami, Myrrha (processed), Radix Cyathulae, Semen Persicae be energy blood circulation promoting and blood stasis dispelling all, improves circulation, logical regulating menstruation road; Radix Cyathulae, energy invigorating the liver and kidney, bone and muscle strengthening, sharp joint; Fructus Toosendan, promoting the circulation of QI to relieve pain, again can dispersing liver-energy, liver governing tendons, irritability is relaxed, and liver blood is prosperous, muscle beniol profit; Radix Glycyrrhizae, tonification healthy energy, coordinating the actions of various ingredients in a prescription.Wine, can relaxing muscles and tendons to promote blood circulation, can strengthen again the efficacy of a drug.All medicine compatibilities in component, can relaxing muscles and tendons to promote blood circulation, dredge the meridian passage, and the eliminating impediment pain of dispelling, arthralgia to osteoarthritis, stiff, enlargement, joint stuffiness have good therapeutic effect.
Technique effect
Technique effect of the present invention is, adopts above-mentioned technical scheme, can realize a kind of medicine for the treatment of osteoarthritis.This medicine is without any side effects, and formula is simple, taking convenience, and cost is low, good effect.Through clinical application for many years, treatment Osteoarthritis more than 400 examples, effective percentage 100%.To courses for the treatment of of most Osteoarthritis (20 days) symptom obviously improve, conventionally 2-3 the course for the treatment of, transference cure, and it is extremely low to recur probability.This medicine also has obvious curative effects for Patients with Cervical Spondylopathy.
Detailed description of the invention
Embodiment 1:
Take Squama Manis 45g, Scorpio 30g, Scolopendra 20g, Flos Carthami 35g, Myrrha (processed) 35g, Radix Cyathulae 40g, Semen Persicae 35g, Fructus Toosendan 30g, Radix Glycyrrhizae 30g, dry dry after, be ground into smalls, or rear 200 mesh sieves of crossing of pulverizing, each 7.5g, every day 2 times, opens wine 50-100ml with temperature and takes after mixing it with water, the rear appropriate diaphoresis of clothes in every 2 day night once, 20 days is a course for the treatment of.
Embodiment 2:
Take Squama Manis 30g, Scorpio 35g, Scolopendra 35g, Flos Carthami 45g, Myrrha (processed) 20g, Radix Cyathulae 30g, Semen Persicae 40g, Fructus Toosendan 35g, Radix Glycyrrhizae 30g, dry dry after, be ground into smalls, or rear 200 mesh sieves of crossing of pulverizing, each 7.5g, every day 2 times, adds appropriate brown sugar with warm water and takes after mixing it with water, after every 2 day night clothes, once (be applicable to alcoholic intolerance person) of appropriate diaphoresis, 20 days is a course for the treatment of.
Embodiment 3:
Take Squama Manis 35g, Scorpio 20g, Scolopendra 30g, Flos Carthami 30g, Myrrha (processed) 20g, Radix Cyathulae 45g, Semen Persicae 45g, Fructus Toosendan 40g, Radix Glycyrrhizae 35g, dry dry after, be ground into smalls, or rear 200 mesh sieves of crossing of pulverizing, each 7.5g, every day 2 times, opens wine 50-100ml with temperature and takes after mixing it with water, the rear appropriate diaphoresis of clothes in every 2 day night once, 20 days is a course for the treatment of.

Claims (1)

1. treat a medicine for osteoarthritis, it is characterized in that component is: Squama Manis, Scorpio, Scolopendra, Flos Carthami, Myrrha (processed), Radix Cyathulae, Semen Persicae, Fructus Toosendan, Radix Glycyrrhizae; Ratio of component is: Squama Manis 10-15%, Scorpio 6-12%, Scolopendra 6-12%, Flos Carthami 10-15%, Myrrha (processed) 6-12%, Radix Cyathulae 10-15%, Semen Persicae 10-15%, Fructus Toosendan 10-15%, Radix Glycyrrhizae 10-15%.
CN201410440521.9A 2014-08-29 2014-08-29 Medicine for treating osteoarthritis Pending CN104173511A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201410440521.9A CN104173511A (en) 2014-08-29 2014-08-29 Medicine for treating osteoarthritis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201410440521.9A CN104173511A (en) 2014-08-29 2014-08-29 Medicine for treating osteoarthritis

Publications (1)

Publication Number Publication Date
CN104173511A true CN104173511A (en) 2014-12-03

Family

ID=51955035

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201410440521.9A Pending CN104173511A (en) 2014-08-29 2014-08-29 Medicine for treating osteoarthritis

Country Status (1)

Country Link
CN (1) CN104173511A (en)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20080105825A (en) * 2007-06-01 2008-12-04 김선정 Herb composition useful for arthritis treatment or prevention and preparation thereof
CN101797291A (en) * 2010-04-01 2010-08-11 孙怀玲 Traditional Chinese medicine for treating osteoproliferation
CN103690637A (en) * 2013-12-31 2014-04-02 纪元元 Osteoproliferation drug and preparation method thereof

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20080105825A (en) * 2007-06-01 2008-12-04 김선정 Herb composition useful for arthritis treatment or prevention and preparation thereof
CN101797291A (en) * 2010-04-01 2010-08-11 孙怀玲 Traditional Chinese medicine for treating osteoproliferation
CN103690637A (en) * 2013-12-31 2014-04-02 纪元元 Osteoproliferation drug and preparation method thereof

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
刘健: "《风湿病中医临床精要》", 31 October 2009, 安徽科学技术出版社 *
李恩: "《中西医防治骨质疏松千题解》", 31 May 2014, 北京科学技术出版社 *

Similar Documents

Publication Publication Date Title
CN100462097C (en) Externally applied ointment for treating hyperosteogeny and preparation method thereof
CN102512630B (en) Traditional Chinese medicine composition for treating gallbladder calculus
CN104398998A (en) Traditional Chinese medicine composition for treating urinary calculi
CN103721080A (en) Traditional Chinese medicine composition for treating cervical spondylosis, lumbar spondylosis and sciatica
CN106266896A (en) A kind of invigorating primordial QI, kidney invigorating and YANG supporting, bone and muscle strengthening, the pill of curing rheumatism
CN102727830B (en) Traditional Chinese medicine calculus removing capsules
CN102988869B (en) Chinese medicinal composition for treating intestinal obstruction
CN104667178A (en) Medicine composition for treating hyperplasia of mammary glands
CN102145143B (en) Pharmaceutical composition for treatment of gastritis and preparation method of pharmaceutical composition
CN104258362A (en) Traditional Chinese medicine preparation for treating peripheral neuritis
CN101708292B (en) Chinese medicament for treating rheumatic and rheumatoid diseases
CN101385839B (en) Traditional Chinese medicine for treating acute mastitis, hyperphasia of mammary glands
CN100434116C (en) Chinese traditional medicine for external application of treating rheumatism like disease, preparation method and usage
CN102370688A (en) Compound Chinese medicinal preparation for treating hyperosteogeny and preparation method thereof
CN104173511A (en) Medicine for treating osteoarthritis
CN104225112A (en) Traditional Chinese medicinal composition for curing osteoarthritis
CN100353995C (en) Pharmaceutical composition with functions of dispersing pathogenic wind, activating collaterals ,and clearing away toxin
CN106474221A (en) A kind of medicine treating osteoarthritis
CN105381168A (en) Backache relieving drug and preparation method thereof
CN106491894A (en) A kind of health medicine formula for treating thyroid nodule
CN104083588A (en) Orthopaedic medicinal liquor for treating lumbar muscle strain and swelling and hard symptom and preparation method
CN104524528A (en) Chinese herb preparation treating anemofrigid-damp arthralgia syndrome
CN104027741A (en) Oral traditional Chinese medicine composition capable of treating female chondromalacia patellae
CN103550614B (en) Traditional Chinese medicine for treating lower-jiao deficiency-cold syndrome type abdominal pain
CN102552821A (en) Chinese medicine for treating knee joint hyperosteogeny

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20141203